RK

Active Director Director DIN 07766298
DIN 07766298 First appointment May 2017 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Raj Kumar

Data last updated:

Raj Kumar is a Director at Elmarc Pharma Private Limited (since 2017). The company operates in Business Services. Elmarc Pharma Private Limited reported revenue of ₹1.5 Lakh (FY 2019).

DIN 07766298
Primary Designation Director
Industry Business Services
First Appointment 01 May 2017
Oldest Company Age 9 yrs
Largest company Elmarc Pharma Private Limited · ₹1.5 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elmarc Pharma Private Limited U74999PB2017PTC046408
Director01 May 20172017₹1.5 Lakh (FY 2019)Active

Board colleagues of Raj Kumar

NameDINCompanyDesignation
Manmohan Sharma07761371Elmarc Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Elmarc Pharma Private Limited
Premium access

Shareholding and investment profile for Raj Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raj Kumar

Raj Kumar currently holds 1 directorship: Elmarc Pharma Private Limited (Director, since 01 May 2017, revenue ₹1.5 Lakh (FY 2019)).

Raj Kumar was first appointed on 01 May 2017 as Director at Elmarc Pharma Private Limited.

The current boards of Raj Kumar's companies include Manmohan Sharma (Elmarc Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available